Atsuya Takeda

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 7

Top Venues

Diagnostics (Basel, Switzerland)

Acta oncologica (Stockholm, Sweden)

Cancers

Hepatology (Baltimore, Md.)

School of Medicine, Keio University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

School of Medicine, Keio University Apr 01 1998 - Mar 31 2004

Japan

PHD

Publications

Masahiro Okada, Kazushi Numata, Hiromi Nihonmatsu, Kengo Tomita, Atsuya Takeda, Kenichiro Tago, Tomoko Hyodo, Takahisa Eriguchi, Masayuki Nakano
Pathological Appearance of Focal Liver Reactions after Radiotherapy for Hepatocellular Carcinoma. Diagnostics (Basel, Switzerland) 12 (5) (2022)
Takahisa Eriguchi, Atsuya Takeda, Takafumi Nemoto, Yuichiro Tsurugai, Naoko Sanuki, Yudai Tateishi, Yuichi Kibe, Takeshi Akiba, Mari Inoue, Kengo Nagashima, Nobuyuki Horita
Relationship between Dose Prescription Methods and Local Control Rate in Stereotactic Body Radiotherapy for Early Stage Non-Small-Cell Lung Cancer: Systematic Review and Meta-Analysis. Cancers 14 (15) (2022)
Takafumi Nemoto, Atsuya Takeda, Yukinori Matsuo, Mitsuhiro Nakamura, Takahisa Eriguchi, Etsuo Kunieda, Ryusei Kimura, Naoko Sanuki, Yuichirou Tsurugai, Masamichi Yagi, Yousuke Aoki, Yohei Oku, Yuto Kimura, Changhee Han, Naoyuki Shigematsu
Applying Artificial Neural Networks to Develop a Decision Support Tool for Tis-4N0M0 Non-Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy. JCO clinical cancer informatics 6 (2022)
Akihiro Funaoka, Kazushi Numata, Atsuya Takeda, Yusuke Saigusa, Yuichirou Tsurugai, Hiromi Nihonmatsu, Makoto Chuma, Hiroyuki Fukuda, Masahiro Okada, Masayuki Nakano, Shin Maeda
Use of Contrast-Enhanced Ultrasound with Sonazoid for Evaluating the Radiotherapy Efficacy for Hepatocellular Carcinoma. Diagnostics (Basel, Switzerland) 11 (3) (2021)
Yuichi Kibe, Atsuya Takeda, Yuichirou Tsurugai, Takahisa Eriguchi, Yohei Oku, Yuto Kimura, Naoki Nakamura
Feasibility of marker-less stereotactic body radiotherapy for hepatocellular carcinoma. Acta oncologica (Stockholm, Sweden) (2021)
Yuichi Kibe, Atsuya Takeda, Yuichirou Tsurugai, Takahisa Eriguchi
Local control by salvage stereotactic body radiotherapy for recurrent/residual hepatocellular carcinoma after other local therapies. Acta oncologica (Stockholm, Sweden) 59 (8) (2020)
Koji Hara, Atsuya Takeda, Yuichiro Tsurugai, Yusuke Saigusa, Naoko Sanuki, Takahisa Eriguchi, Shin Maeda, Katsuaki Tanaka, Kazushi Numata
Radiotherapy for Hepatocellular Carcinoma Results in Comparable Survival to Radiofrequency Ablation: A Propensity Score Analysis. Hepatology (Baltimore, Md.) 69 (6) (2019)

Atsuya Takeda.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Atsuya Takeda